Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat for ocular inflammation and pain after cataract surgery
NCT01298752Phase 3Terminated
- Sponsor
- Bausch + Lomb
- Start
- Feb 2011
- Primary completion
- Sep 2011
- Countries
- 1
01
Overview
A Phase 3 trial of mapracorat in ocular inflammation, pain, sponsored by Bausch + Lomb. Started Feb 2011; status: terminated.
02
Drugs
mapracorat
03
Conditions
ocular inflammationpain
Beyond the preview
Go deeper on NCT01298752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298752.